| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 11 |
| 1 | ASPIRIN | 10 |
| 2 | ASPIRIN 325 MG | 10 |
| 3 | ASPIRIN 81 MG | 10 |
| 4 | FUROSEMIDE | 9 |
| 5 | CYTARABINE | 7 |
| 6 | ALBUTEROL | 5 |
| 7 | ALBUTEROL SULFATE | 5 |
| 8 | ALLOPURINOL | 5 |
| 9 | CARBOPLATIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TETRACAINE HYDROCHLORIDE | 1 | 0.0075 |
| 1 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 1 | 0.0028 |
| 2 | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 1 | 0.0025 |
| 3 | SEVELAMER HYDROCHLORIDE | 1 | 0.0017 |
| 4 | DEXTROMETHORPHAN HBR, GUAIFENESIN | 1 | 0.0010 |
| 5 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 6 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 7 | FLUVASTATIN SODIUM | 2 | 0.0004 |
| 8 | ZINC SULFATE INJECTION, | 1 | 0.0003 |
| 9 | DEXMEDETOMIDINE HYDROCHLORIDE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 18 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 10 |
| 4 | Platinum-based Drug [EPC] | 10 |
| 5 | Loop Diuretic [EPC] | 9 |
| 6 | Proton Pump Inhibitor [EPC] | 9 |
| 7 | Benzodiazepine [EPC] | 7 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 7 |
| 9 | Insulin Analog [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin [EPC] | 1 | 0.0003 |
| 1 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 2 | 0.0001 |
| 3 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 4 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Oxazolidinone Antibacterial [EPC] | 2 | 0.0001 |
| 6 | Anticholinergic [EPC] | 1 | 0.0001 |
| 7 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 8 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |